Keck School of Medicine of USC receives its highest ranking in NIH funding
USC departments in ophthalmology and preventive medicine are No. 2 in the United States.
USC and Children’s Hospital Los Angeles receive nearly $37 million grant
The National Institutes of Health award allows scientists to continue work in patient and community health.
After death, twin brains show similar patterns of damage
Researchers led by USC psychologist Margaret Gatz compare the brains of twins in which one or both died of Alzheimer’s.
Practice makes perfect in applying for federal grants
Applying to the National Institutes of Health for grants is among the most challenging of hurdles for early career biomedical researchers.
Genetic link to Type 2 diabetes found
Keck School scientists are part of an international team that has uncovered a new genetic clue that contributes to an increased risk of developing Type 2 diabetes.
Stem cells offer clues to reversing receding hairlines
Regenerative medicine may offer ways to banish baldness that don’t involve toupees.
USC study suggests brain blood vessels alter Alzheimer’s progression
New research from USC suggests that cells in the blood-brain barrier may control multiple steps in the progression of Alzheimer’s disease.
MRI helps doctors examine effects of cholesterol meds
Researchers in a multiyear study are using magnetic resonance imaging to understand the long-term effect of statins drugs on arterial blockages.
Saxbe study gets under the skin
It’s difficult to forget the harrowing images of emaciated, hollow-eyed Romanian orphans whose plight was revealed after the fall of Communist leader Nicolae Ceausescu’s brutal regime in 1989.
Carving out more research time for surgeons
The Department of Surgery will fund one of its faculty’s participation in the clinical researcher education curriculum.
USC study reveals a protein that keeps people organized
Most people think that their planners or iPhones keep them organized, when proteins such as liver kinase b1 (Lkb1) actually have a lot more to do with it.
Researchers target drug-resistant strains of HIV
USC researchers have demonstrated a way to generate potential new drugs to halt the replication of HIV in infected patients by inhibiting a crucial enzyme in the virus’ reproductive cycle.
New grant bolsters Keck School’s study of Kaposi’s sarcoma
The National Institutes of Health has awarded Keck School researchers a $7.5 million grant to investigate how Kaposi’s sarcoma-associated herpesvirus evades the immune system and triggers certain cancers.
Keck Medicine researchers to examine if vitamin D prevents diabetes
Keck Medicine researchers seek volunteers to take part in the first large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay Type 2 diabetes in adults who have prediabetes.
Experimental drug could lead to possible stroke therapy
An experimental drug appears to reduce brain damage, eliminate brain hemorrhaging and improve motor skills in older stroke-afflicted mice and stroke-afflicted rats.
Brainpower applied to understanding of neural stem cells
How do humans and other mammals get so brainy? USC researcher Wange Lu and his colleagues shed new light on this question in a paper published in the journal Cell Reports.
USC professors study role of DNA enzyme in cancer
Chemotherapy offers cancer patients hope of a cure or at least of remission. The problem with the treatment is that all too often a hard-won remission is only temporary.
USC researcher learns how to break a sweat
In a recent paper, USC researchers explored the ultimate origin of a sticky, stinky but vital substance — sweat gland stem cells.
Keck School charts effects of genetic mutation linked to Alzheimer’s
People who carry a genetic mutation associated with Alzheimer’s disease may develop the disease three years earlier than expected.
USC, UCLA to develop stroke center network in Southland
A three-way partnership that includes USC has been awarded a $2 million grant from the National Institutes of Health to address stroke.
Delayed aging is better investment than cancer, heart disease research
A new study showed that research to delay aging and the infirmities of old age would have better population health and economic returns than advances in individual fatal diseases.
USC study unlocks biology with math
Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity.
USC scientists ID protein with potential for anticancer therapy
Molecular microbiologists at USC have uncovered intricate regulatory mechanisms within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases.
Cancer-killing cells controlled by epigenetic process, new study shows
A new Keck School study has described how natural killer cells in the human body, which can kill and contain viruses and cancerous tumors, can be manipulated by epigenetics.